McGrath Yvonne has filed 3 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 15300 shares of iTeos Therapeutics, Inc. ($ITOS) on March 07, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 7, 2025 | iTeos Therapeutics, Inc. | $ITOS | McGrath Yvonne | Chief Scientific Officer | A | Common Stock | 15300 | $0.00 | 46,300.0000 | 38,194,341 | 49.35% | 0.04% |
| March 7, 2025 | iTeos Therapeutics, Inc. | $ITOS | McGrath Yvonne | Chief Scientific Officer | A | Stock Option (Right to Buy) | 91000 | $0.00 | 91,000.0000 | 38,194,341 | 9999.99% | 0.24% |
| March 7, 2024 | iTeos Therapeutics, Inc. | $ITOS | McGrath Yvonne | Chief Scientific Officer | A | Stock Option (Right to Buy) | 153600 | $0.00 | 153,600.0000 | 0 | 9999.99% | 0.00% |